Fish oil showdown: EPA vs DHA in diabetes prevention trial
NCT ID NCT07575438
First seen May 10, 2026 · Last updated May 10, 2026
Summary
This study tests whether two types of fish oil, EPA and DHA, can improve metabolic health in people with obesity who are at high risk for type 2 diabetes. Over 12 weeks, 84 participants will take daily capsules of EPA, DHA, or a placebo (corn oil) and undergo specialized tests to measure insulin function, cholesterol quality, and fat tissue health. The goal is to see if one type of fish oil is better at reducing diabetes risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut de recherches cliniques de Montréal (IRCM)
Montreal, Quebec, H2W 1R7, Canada
Contact Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.